DAVID GRANOVSKY

Archive for January, 2010|Monthly archive page

JACK BAUER GETS STEM CELLS ON 24!

In CELEBRITIES & STEM CELLS on January 21, 2010 at 4:46 pm
Kiefer: Jack Bauer’s family mission

Kiefer Sutherland has revealed that Jack Bauer is desperate to get his family back in the new series of 24.

The last season saw Kiefer’s character facing death after exposure to a bioweapon and daughter Kim (Elisha Cuthbert) – with whom he’d had a tricky relationship – volunteering to try and save his life with a stem cell procedure.

Now Jack hopes to build on Kim’s change of heart, with Kiefer saying: “He has the opportunity to start a life with his granddaughter, and through his granddaughter he sees an opportunity of repairing the relationship with his daughter – he is very committed to trying to get back that family that he lost from season one.”

Kiefer: Jack Bauer's family mission

“OPTIC NERVE TREATMENT ABANDONED” or “HOW TO REGRET FOR THE REST OF YOUR LIFE”

In STEM CELLS IN THE NEWS on January 21, 2010 at 11:45 am
“OPTIC NERVE TREATMENT ABANDONED” or
“HOW TO REGRET FOR THE REST OF YOUR LIFE”

It saddens me to see people who are on the brink of improvement for their child’s condition are turned away at the door by anti-adult stem cell nay-saying UK doctors. This event will reverberate in their lives for years to come…and unfortunately I believe the parents will regret their choice for years to come. (my comments in red) -dg

Imogen James

Imogen James has a condition known as Optic Nerve Hypoplasia

The parents of a girl with sight problems have given up plans to take their daughter  for stem cell therapy.

Lauren and Nick James’ daughter Imogen suffers from an underdeveloped optic nerve which makes her virtually blind.  Her parents believed this treatment would work miracles on their daughter’s sight.  They raised over £28,000 to pay for the operation but will now return the money and give the rest to charity.

‘Former Optic Nerve Hypoplasia Patient and Stem Cell Recipient Dakota Clark is Doing fantastic’

Imogen James was born with Optic Nerve Hypoplasia which is congenital condition (i.e. present at birth). It means that Imogen is virtually blind and can only see things if they are extremely close to her. Lauren first heard about the stem cell treatment a year ago which filled her with hope.  “A year ago we met with Dakota Clark’s family who’d just been to China for stem cell therapy and they had given rave reviews, [saying] how fantastic it was and how Dakota had started walking, her eyesight was better, her speech was better and she was doing fantastic. “I’ll admit at the time I thought, ‘wow this is unbelievable’ so that gave us the boost.”

Stem cell therapy aims to replace or repair damaged cells but according to the NHS ”the range of diseases where stem cell treatment is proven treatment option is still quite small”.

A few comments about this:

  • Adult or Repair “stem cell treatment is (a) proven treatment option” in over 170 diseases (not very small)…in about ~2000 clinical trials, ~30-40,000 scientific papers and thousands of success stories.
  • Nat’l Health Services or NHS provides treatments to patients so their commenting on competing medical options  is extremely suspect and a conflict of interest.
  • I recently commented on an NHS article on MS with “More Info about MS and Stem Cells – http://repairstemcell.wordpress.com/2009/09/02/multiple-sclerosis-and-stem-cells-need-more-info/ ” My comments were removed.

They needed to raise £30,000 to pay for the operation and the flights.  After raising £28,000 in a matter of months, the family was all set to go ahead and had booked flights for December 2009.  So close…so close…

But then the doubts set in. “Obviously during that time we were doing a lot of research ourselves but the more and more we dug into the stem cell therapy the more answers I wasn’t finding.  “I was finding a lot of questions, but I wasn’t finding any answers and unfortunately the company we were going to see, they were sort of evasive with the answers in a way, but I found out from speaking to doctors in the UK that they don’t have the answers either – no-one has.”  The treatment itself involves using an intravenous drip to feed the stem cells into the body, or by using a lumbar puncture .

I have seen the answers that this treatment center (one of the most reputable treatment centers in the world) gives.  They are respectful and honest and they are unwilling to make forward looking or optimistic statements.  Interested patients receive the facts and nothing more.  They will give you the results and experiences and data but no guarantees or promises because they can not and will not out of responsibility to their patients and their own integrity.  This is not evasive, this is the way it should be!

I feel terrible for the Jameses.  I wish them the best and hope Imogen’s condition improves every day.  I hope they don’t regret this decision for the rest of her life…but I’m afraid they will.  I hope they don’t become convinced in 2 months that stem cells are the way to go…but I’m afraid they will.  I hope they have read everything available on stem cell treatment of optic nerve hypoplasia [ http://repairstemcell.wordpress.com/?s=optic+nerve ] …the story of Macie Morse who went from legally blind to driving a car, the story of American Idol candidate Devin Riley, the story of the 40 or 50 more (and counting) ONH, SOH and MD (macular degeneration) patients whose sight has improve considerably since stem cell treatment and whose quality of life improvements are off the charts.

In retrospect, I hope they haven’t.  If they have seen all of this evidence and come so close and then still turned away is as bewildering to me as it is tragic. Sigh… I wish I could help them…maybe I still can. I don’t know… Perhaps they will see this and read all of the information available.  I’d like to help if I can…

“But few have spoken of the actual pleasure derived from giving to someone, from creating something, from finishing a task, from offering unexpected help almost invisibly and anonymously.”  Paul Wiener quotes

-David

http://img180.imageshack.us/img180/7520/youcanleadahorsetowateran2.jpgYou can lead a horse to water, but you can’t make him drink.

[something that you say which means you can give someone the opportunity to do something, but you cannot force them to do it if they do not want to - Cambridge Idioms Dictionary, 2nd ed. ]

1ST STEM CELL BREAST AUGMENTATION??

In VICTORIES & SUCCESS STORIES on January 20, 2010 at 3:59 pm

This is not the first, not by a long shot…but I’m glad to see the US is starting to catch on that adult/repair stem cells have amazing therapuetic capabilities…even if they are only going to use them for cosmetic surgery and ignore the millions dying each year around the world of what the world and studies and trials have determined can be safely and effectively treated with stem cells….designating hundreds of diseases classified as no-option or incurable or untreatable as ”stem cell TREATABLE diseases” …

…the same diseases that are also classified as stem cell UNTREATABLE in the US. 

SIgh….it’s a start, it’s a start, it’s a start…. dg

First Regenerative Cell Breast Augmentation Surgery Performed Through Stem Cell Assurance Physician Network
Companies:

Related Quotes

Symbol Price Change
SCLZ.PK 0.0140 +0.0020

Press Release Source: Stem Cell Assurance, Inc. On Wednesday January 20, 2010, 9:30 am EST

BOCA RATON, Fla., Jan. 20 /PRNewswire-FirstCall/ — Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) announced today that an MD., F.A.C.S. has performed the first regenerative cell breast augmentation through its nationwide physician network.  The procedure was performed in the practice’s onsite accredited ambulatory surgical facility.  

The patient treated underwent regenerative cell breast augmentation on Monday with the goal of an approximate one cup size increase in each breast.  Fat was taken from her hips and thighs by tumescent liposuction and processed to extract naturally-occurring regenerative cells.  Commenting after the surgery, the doctor stated, “Today is a defining moment in breast augmentation surgery.  The offering of this pioneering procedure through a collaborative national physician network is an important milestone that marks major improvement on current technology and the way in which it is delivered to the patient.”

‘Fountain of youth’ for stem cells?

In SCIENCE & STEM CELLS on January 13, 2010 at 5:20 am

‘Fountain of Youth’ for Stem Cells?

ScienceDaily (Dec. 29, 2009) — Researchers from the University of Hong Kong and the Massachusetts Institute of Technology have published a study in the current issue of Cell Transplantation that explores ways to successfully keep stem cells “forever young” during implantation by slowing their growth, differentiation and proliferation.

See Also:

Health & Medicine

* Stem Cells

* Immune System

* Brain Tumor

* Lymphoma

* Prostate Cancer

* Skin Cancer

Reference

* Embryonic stem cell

* Somatic cell

* Healing

* Biological tissue

“The successful storage and implantation of stem cells poses significant challenges for tissue engineering in the nervous system, challenges in addition to those inherent to neural regeneration,” said Dr. Ellis-Behnke, corresponding author. “There is a need for creating an environment that can regulate cell activity by delaying cell proliferation, proliferation and maturation. Nanoscaffolds can play a central role in organ regeneration as they act as templates and guides for cell proliferation, differentiation and tissue growth. It is also important to protect these fragile cells from the harsh environment in which they are transplanted.”

According to Dr. Ellis-Behnke, advancements in nanotechnology offer a “new era” in tissue and organ reconstruction. Thus, finding the right nano-sized scaffold could be beneficial, so the research team developed a “self-assembling nanofiber scaffold” (SAPNS), a nanotechnology application to use for implanting young cells…

via ‘Fountain of youth’ for stem cells?.

Clinical trial of adult stem cells in heart attack reports on safety and efficacy

In VICTORIES & SUCCESS STORIES on January 13, 2010 at 5:17 am

SLOWLY Catching Up…

Sections:

Phase I trial of bone marrow stem cells in patients who had suffered a myocardial infarction. Safety was good and patients receiving the stem cell injections appeared to recover better.

The results of a Phase I trial looking at outcomes for heart attack patients treated with adult stem cells have concluded that the treatment is safe and should go forward to Phase II efficacy trials.

  • 53 patients from ten centers across the USA
  • received one of three doses of bone marrow stem cells or placebo
  • a purified formulation of mesenchymal stem cells
  • injected intravenously into the leg or arm within 10 days of the heart attack
  • patients were then monitored over 2 years to assess any side effects and recovery was measured using a variety of imaging techniques, measures of heart function and symptom scores.

“The results point to a promising new treatment for heart attack patients that could reduce mortality and lessen the need for heart transplants,” commented Gary Schaer, principal investigator at Rush University.

There was no evidence of any increase in adverse events in the stem cell- versus placebo-treated patients. Hematological parameters and markers of kidney and liver function were not different between the groups. Patients receiving stem cells showed greater improvement in symptoms, better heart function and fewer arrhythmias than patients receiving placebo after 6 months. There was also evidence of better lung function in the treatment group.

These results, recently published in the Journal of the American College of Cardiology, were considered sufficiently positive to proceed to a Phase II efficacy trial, which is currently recruiting.

“It is suspected that these stem cells may take part in the growth of new blood vessels to bring more oxygen to the heart and help reduce the scarring from a heart attack,” stated Dr Schaer.

The cells used in this study were mesenchymal stem cells harvested from the bone marrow of healthy unrelated adult donors. The researchers involved in the study feel that mesenchymal stem cells have advantages for clinical use in that they do not provoke immune reaction, are easy to prepare and have been extensively tested for this indication in animal studies.

“This study suggests that adult bone marrow derived stem cells are more flexible than previously thought … if the benefits and safety are confirmed in the ongoing Phase II trial, we may soon have a remarkable new therapy.”

via Future Medicine – Regenerative Medicine – 5(1):7 – Full Text.

The Search for Autism’s Missing Piece : Autism Research Slowly Turns Its Focus to Environmental Toxicity

In SCIENCE & STEM CELLS on January 13, 2010 at 5:08 am

The Search for Autism’s Missing Piece

Autism Research Slowly Turns Its Focus to Environmental Toxicity

By Brita Belli

© William Duke

Autism cases are on the rise. Or so the most recent data would have us believe. The Centers for Disease Control and Prevention (CDC) found that 1 in 100 children in the U.S. have been diagnosed with autism spectrum disorder (ASD)—up from 1 in 150 in 2007. A study in the journal Pediatrics in October 2009 revealed similar numbers—parents of 1 in 90 children reported that their child had ASD. With boys, the rate of ASD was 1 in 58. Without a doubt, autism is the country’s fastest-growing developmental disability, affecting more children than cancer, diabetes and AIDS combined. Still, in dealing with a childhood disorder that ranges from “highly functioning” to uncommunicative, and such a long list of potential triggers and treatments, even the numbers themselves are subject to questioning…

…Marty Ann Kelly, a mother from Maine affiliated with T.I.A., bought a mild hyperbaric oxygen chamber for her home to treat her son, Kenneth, now 8 years old. She has also taken him for stem cell injections taken from umbilical cord blood. There, he was injected with 24 million stem cells over four days; and she plans to return. “We believe this will bring him to recovery,” she says, adding: “We are fanatical about understanding autism, what is causing it and how to help combat it better every day, week and month…For the last three years, we have been studying biomedical interventions and using parent-based online-forum analysis to uncover the reasons for his autism.”

“STEM CELLS FOR AUTISM – PROGRESS TO DATE”

http://repairstemcell.wordpress.com/2009/10/26/stem-cells-for-autism/


via The Search for Autism’s Missing Piece : Autism Research Slowly Turns Its Focus to Environmental Toxicity (By Brita Belli).

Women with breast cancer may benefit from autologous stem cell transplantation

In ALL ARTICLES on January 12, 2010 at 9:37 pm

Women With Breast Cancer May Benefit from Autologous Stem Cell Transplantation

ScienceDaily (Jan. 12, 2010) — Compared to conventional chemotherapy, autologous stem cell transplantation can extend “event-free survival” for breast cancer patients. Clinical trials provide proof of this for breast cancer with and without distant metastases. However, there are indications that this type of stem cell transplantation can more frequently give rise to severe complications affecting almost all organ systems. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 16 December 2009.

See Also:

Health & Medicine

* Breast Cancer

* Lung Cancer

* Prostate Cancer

* Cancer

* Colon Cancer

* Stem Cells

Reference

* Metastasis

* Bone marrow transplant

* Breast cancer

* Skin grafting

In autologous stem cell transplantation (autologous SCT), the patient’s own (autologous) haematopoietic stem cells are removed at a suitable time during treatment and re-implanted after high-dose chemotherapy. Initially, this treatment was hailed with great excitement and widely used in the 1980s, but its benefit for patients with advanced breast cancer has been hotly debated by scientists for some years. The Federal Joint Committee (G-BA) therefore commissioned IQWiG to examine the available literature to find out whether autologous SCT could have advantages for breast cancer patients compared to conventional chemotherapy.

via Women with breast cancer may benefit from autologous stem cell transplantation.

Double transplant for type 1 diabetes brings troubles, gifts

In ALL ARTICLES on January 11, 2010 at 3:05 pm

Double transplant for type 1 diabetes brings troubles, gifts
Updated 1/11/2010 12:05 PM ET    E-mail | Save | Print

Enlarge    By Dan MacMedan, USA TODAY

Immersing himself in a hot bath while taking anti-nausea pills brings Scott Bowles some relief from cyclic vomiting syndrome.

By Scott Bowles, USA TODAY

Ten years ago Tuesday, USA TODAY’s Scott Bowles had a kidney and pancreas transplant to treat his juvenile diabetes. He kept a journal of the experience, which ran as a series in the newspaper and in his book, The Needle and the Damage Done. Bowles, 44, a film reporter in Los Angeles, looks back at the decade and life after the surgery.

Albuquerque, April 7, 2009
Denzel Washington is going to have to wait.
The star is on a nearby stage, rehearsing

But I’m not going to make it. I’m on the floor of a publicist’s darkened office, on my back, trying to slow my breathing and fight off the nausea and heart palpitations that are racking my body.
READ MORE: Type 1 diabetes’ effect on daily life
Again.

It has been 10 years since I opted to treat my diabetes with a kidney and pancreas transplant, a decision that, for the first time, I’m beginning to question.

I find myself on a hospital gurney with frightening regularity lately. Where once I was going to the hospital every six to eight months, now I’m there every six to eight weeks. My weight is down to 139, lighter than I was in college. Three days without nausea or a racing heart feels like a good stretch of health.

More frightening, doctors aren’t sure how to keep my body from breaking down. They’ve diagnosed me with two post-transplant illnesses: cyclic vomiting syndrome (CVS) and atrial fibrillation. CVS is a powerful wave of nausea that hits without warning and can last hours, leaving me heaving long after my stomach is empty.
The nausea depletes me of electrolytes and minerals, which sends my body into the more dangerous complication: atrial fibrillation, a condition in which the heart pumps twice as fast as normal but circulates only 60% of the blood, raising the risk of a blood clot and stroke.

Today, I’m in the throes of both complications. I’m rushed to New Mexico University Hospital, where nurses are having trouble finding a vein. I’ve had so many blood draws over the decade that my veins have scarred and it’s difficult to find one that’s usable.

They try two sticks in the left arm. No luck. One in the right. Same result.
A nurse suggests mining my neck. I close my eyes: This is the one place I thoroughly feel the needle. The vein works all right; it’s dashing us both in arterial spray, too much for her to secure an intravenous tube. Finally, she sinks the needle between the fingers of my right hand and finds a vein.
After a bit, I feel the medications open my lungs and nudge me toward sleep.
But not before I think to myself: I can’t keep doing this.

Los Angeles, July 14
My doctor for the past 10 years, Michael Brousseau, has me in his office. My mother is here, too. She has traveled from Atlanta to meet with physicians and brainstorm.

Brousseau is frustrated. I’m on a dozen anti-nausea medications — some of them designed for cancer patients on chemotherapy — yet nothing works with consistency.
He connects me with two more specialists, who will focus on my stomach and heart. “Something has to work,” he says. “Because right now, you’re not functional.”

The words throw me. I had this surgery Jan. 12, 2000, as a salvo against the disease, which over 20 years claimed both kidneys, one-third of my sight and almost all hope that I’d reach 50 with my vision and limbs intact.
And for five years, it seemed, the transplant was the solution. To this day I’ve had no rejection episodes and not a drop of insulin.

But the new complications are frighteningly quick and forceful. I was never staggered by an insulin reaction or high blood sugar as I am by these side effects.

We drive home, and I excuse myself to the bathroom. I run a hot bath (the one treatment that seems to settle my nausea) and turn up the radio so Mom can’t hear me lose my composure in the tub.
Maybe I don’t beat my body’s demons. Maybe I already was as healthy as I’m ever going to be.

July 16
Mom and I are walking through the mall when I lose my balance. The new medications are interacting poorly, leaving my head swimming and my legs unreliable. I flop in a mall seat while Mom goes for something to drink.
A woman who has been watching from a nearby bench walks toward me. She holds a package of gum and offers me a piece.

I’m not sure how to respond, so I take it and thank her. She shakes her head — she doesn’t speak English — but smiles and offers another piece.
The gum does nothing, the gesture everything. By the time Mom is back, I’m already feeling better, energized by the random kindness of the woman, who nods and smiles as Mom and I pad off.
This disease can offer such odd, sweet consolation prizes.

Sept. 16
A nurse calls me at home, the first time I’ve heard from my insurance company unsolicited.
“It appears you’ve been having some complications of late,” she says. “Is there anything we can do?”
I’m cautious. I’m getting two dozen bills, letters from hospitals and benefits explanations every month now, and I must be signaling a red flag with the insurance company. My anti-rejection drugs have jumped from $1,200 a year to $2,800. And that doesn’t include hospital stays, ER visits or nausea medications that run $150 a week.
No, thank you, I tell her. We have specialists working on it.

She presses a little more, asking for some details of my recent hospitalizations. She gently asks whether this is a new problem or something “that might have been pre-existing.”
I freeze. I know what that phrase means. It means you’ve become too expensive to keep healthy. No, I say flatly before getting off the phone, it’s a new problem.

Fortunately, I didn’t have to lie. This is new. I could use help. But I’m not sure she’s offering it, and I would have told her my nose wasn’t a pre-existing condition if my insurance were at stake.

Nov. 1
My good friend Jocelyn Smith is visiting when I feel my hands and feet go numb — the surest signal I’m headed into atrial fibrillation.

Without a word, she jumps into action. She eases me into her car, drives me to the hospital and gives the doctors the rundown on my medications and symptoms. She stays the duration of the six-hour wait for a bed.
Somehow, this trip to the hospital is easier than the others.

Maybe it’s seeing Jocelyn oversee the chaos like a M.A.S.H. nurse. I’ve watched as my friends and family turn into a team of first responders: paramedics, doctors, ambulance drivers. All without asking or asking anything in return.
Not that there’s any way to repay what they’ve given me.

Dec. 11
I’m beginning to understand how dogs improve and lengthen the lives of the elderly. Mine are making this place more homey.

When I’m ill in the bath, I notice, they quit roaming the house and cram into the bathroom. My golden retriever, Teddy, curls up by the tub. Esmé, a diminutive Boston terrier who acts as his orbiting moon, nestles into his belly.
I don’t want to be that crazy dog guy, but I’m convinced their company helps. It’s comforting to reach over the tub and bury my hands into that warm, tangled fur pile, something that could have sprung from Where the Wild Things Are.

I’ve read the studies that say domestic animals have learned over the years to befriend humans to maximize food and shelter from us.
But I prefer to think they can’t stand the thought of me being alone or sick.

Dec. 25
This could be a strange Christmas. Because the nausea and A-fib can strike so suddenly, I can’t risk being on a plane for five hours to visit my family in Atlanta. This will be the first Christmas I don’t make it home for some part of the holiday season.

I wake up ready to dread the day, but my body has surprised me. No nausea, no heart-skipping.
I decide to spend the day visiting people dear to me: Anthony Breznican, who cooks for me more than I do; Luz Elena Avitia, who has become a surrogate parent to my dogs when I’m sick; and Michael Ingram, an old friend who offered me one of his kidneys 10 years ago.

The trip isn’t without risk. Luz and Michael are in San Diego, and the complete drive will take at least five hours — as long as a flight.
But I’m tired of my body caging me. I stuff a few meds in my jeans and hit the road.
The day flies. Everyone is in good spirits, my heart is behaving and by the time I’m driving back, I’ve forgotten how long I’d gone without a moment of nausea.

When I get home, I realize that I haven’t opened any presents under the tree. I know it’s corny, but this Christmas — filled only with people I love — has a Seuss-ian feel to it. I go to bed without touching a gift. I’ll do that tomorrow.
Tonight, I’d like to remain that Who in Whoville.

Jan. 9, 2010
Tuesday marks what I consider my 10th birthday: the day I received my organs.

It also marks the day Valerie and Leroy Flegel took their 21-year-old son, Samuel, off life support.
I have trouble reconciling this. How does that much despair create that much hope?

Samuel was, by all accounts, an extraordinary young man. Born with a learning disability similar to dyslexia, he overcame it to earn his GED and become an engineer for Red River Valley and Western Railroad in Wahpeton, N.D.
He was riding home from a New Year’s party in Fargo in 2000 when he hit a parking lot abutment hidden in snow. By the time police found him, he was brain-dead, though the subzero temperatures kept his body alive.
Now I carry him.

For some reason, I rarely get sick around the anniversary date, and this time is no different. I wake up hungry, energized. Healthy. I hop in the car and drive for a doughnut, something I could never have eaten as a diabetic.
On the drive back, I’m a little angry at myself for being so self-pitying, for questioning this fight. There is no beating diabetes, just changing the complications. But at least I have a chance for better health, something Samuel never got.

And perhaps more than any other anniversary, this one reminds me that I do not fight alone. Through all this, friends have become family and family has become closer than it has ever been. Strangers have offered whatever they have. I think of them and it propels me, literally.
I am awake now, opening up the accelerator as I drive home. Music rattles the windows of the car. I don’t want the drive to end.

I speed past the exit for my house. The morning is bleeding into afternoon, and it’s too warm, too nice to stop moving. I’m going to drive until I run out of gas.
For every day I spend sick or in a hospital, it seems, I receive one that is equally fine. That’s where I discovered the unexpected gift of diabetes, one that I would never return: the capacity to recognize and enjoy the moment.
A nausea-free morning. A symptom-free afternoon. A good day.
Like this one.

DRUG CORRUPTION, SWINE FLU + NEEDLESS DEATHS

In ALL ARTICLES on January 10, 2010 at 3:05 pm

“one of the greatest medicine scandals of the Century”

-Dr. Wolfgang Wodarg, former SPD Member of the German Bundestag and now chairman of the Health Committee of PACE (Parliamentary Assembly of the Council  of Europe)

European Parliament to Investigate WHO and “Pandemic” Scandal

http://www.iepfpd.org/images/sites/European-Parliament.jpg

The Council of Europe member states will launch an inquiry in January 2010 on the influence of the pharmaceutical companies on the global swine flu campaign, focusing especially on extent of the pharma‘s industry’s influence on WHO. The Health Committee of the EU Parliament has unanimously passed a resolution calling for the inquiry. The step is a long-overdue move to public transparency of a…

“Golden Triangle” of drug corruption between WHO, the pharma industry and academic scientists that has permanently damaged the lives of millions and even caused death.


The parliament motion was introduced by Dr. Wolfgang Wodarg, former SPD Member of the German Bundestag and now chairman of the Health Committee of PACE (Parliamentary Assembly of the Council  of Europe). Wodarg is a medical doctor and epidemiologist, a specialist in lung disease and environmental medicine, who…

considers the current “pandemic” Swine Flu campaign of the WHO to be “one of the greatest medicine scandals of the Century.”[1]


The text of the resolution just passed by a sufficient number in the Council of Europe Parliament says among other things, “In order to promote their patented drugs and vaccines against flu, pharmaceutical companies influenced scientists and official agencies, responsible for public health standards to alarm governments worldwide and make them squander tight health resources for inefficient vaccine strategies and needlessly expose millions of healthy people to the risk of an unknown amount of side-effects of insufficiently tested vaccines. The “bird-flu”-campaign (2005/06) combined with the “swine-flu”-campaign seem to have caused a great deal of damage not only to some vaccinated patients and to public health-budgets, but to the credibility and accountability of important international health-agencies.”[2]

http://scrapetv.com/News/News%20Pages/Health/Images/swine-flu-pigs.jpg

FULL STORY HERE: http://www.globalresearch.ca/index.php?context=va&aid=16667

China surpasses Canada in stem cell advances: report

In VICTORIES & SUCCESS STORIES on January 8, 2010 at 3:04 am

China surpasses Canada in stem cell advances: report

Margaret Munro, Canwest News Service Published: Thursday, January 07, 2010

Stem cells that were extracted from cow bone marrow is cultured in petri dishes J.P. Moczulski for National Post Stem cells that were extracted from cow bone marrow is cultured in petri dishes

China is seen as a wild frontier when it comes to unproven stem cell treatments, but a new report says it has surpassed Canada with legitimate and dramatic advances in the field.

Scientists in China, many of them trained at North American and European universities, published 1,116 articles on stem cells in international peer-reviewed journals in 2008, up from just 37 papers in 2000, says a team at the University of Toronto documenting China’s aggressive bid to become a major player in regenerative medicine.

China has now surpassed Canada and Australia to become the world’s fifth most prolific contributor to the exploding field that promises repair for ailing organs and tissues, the report says.

via China surpasses Canada in stem cell advances: report.

Follow

Get every new post delivered to your Inbox.

Join 727 other followers